Sale!

CHMP2B Gene Amyotrophic lateral sclerosis type 17 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CHMP2B Gene Amyotrophic Lateral Sclerosis Type 17 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CHMP2B gene that are linked to Amyotrophic Lateral Sclerosis (ALS) Type 17. ALS, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to loss of muscle control. Type 17 ALS, associated with mutations in the CHMP2B gene, is a rare form of the disease that can be familial or sporadic. This genetic test plays a crucial role in the early detection and diagnosis of ALS Type 17, enabling healthcare professionals to devise appropriate management and treatment plans for affected individuals. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test is priced at 4400 AED. The accurate identification of CHMP2B gene mutations through this test is vital for understanding the disease’s progression, potential familial risk, and exploring targeted therapeutic strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CHMP2B Gene Amyotrophic lateral sclerosis type 17 Genetic Test

Welcome to DNA Labs UAE, where we offer the CHMP2B Gene Amyotrophic lateral sclerosis type 17 Genetic Test. This test is used to analyze the CHMP2B gene and identify any mutations or variations associated with ALS type 17.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the CHMP2B Gene Amyotrophic lateral sclerosis type 17 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with CHMP2B Gene Amyotrophic lateral sclerosis type 17.

Test Details

The CHMP2B gene is associated with a rare form of amyotrophic lateral sclerosis (ALS) known as ALS type 17. This type of ALS is characterized by progressive muscle weakness and wasting, leading to difficulty with movement, speaking, and breathing.

NGS (next-generation sequencing) genetic testing is utilized to analyze the CHMP2B gene and identify any mutations or variations that may be associated with ALS type 17. This type of testing can aid in the diagnosis of the condition and provide information for genetic counseling and symptom management.

It is important to note that genetic testing for ALS type 17 is not routinely performed. It is typically recommended for individuals with a strong family history of the condition or those who have already been diagnosed with ALS and are not showing typical symptoms. Additionally, genetic testing alone cannot confirm a diagnosis of ALS and should be used in conjunction with other diagnostic tools, such as clinical evaluation and electromyography (EMG) testing.

Test Name CHMP2B Gene Amyotrophic lateral sclerosis type 17 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CHMP2B Gene Amyotrophic lateral sclerosis type 17 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CHMP2B Gene Amyotrophic lateral sclerosis type 17
Test Details

The CHMP2B gene is associated with a rare form of amyotrophic lateral sclerosis (ALS) known as ALS type 17. This type of ALS is characterized by progressive muscle weakness and wasting, leading to difficulty with movement, speaking, and breathing.

NGS (next-generation sequencing) genetic testing can be used to analyze the CHMP2B gene and identify any mutations or variations that may be associated with ALS type 17. This type of testing can help diagnose the condition and provide information for genetic counseling and management of symptoms.

It is important to note that genetic testing for ALS type 17 is not routinely performed and is typically only recommended for individuals with a strong family history of the condition or those who have already been diagnosed with ALS and are not showing typical symptoms. Additionally, genetic testing alone cannot confirm a diagnosis of ALS and should be used in conjunction with other diagnostic tools, such as clinical evaluation and electromyography (EMG) testing.